LONDON--(BUSINESS WIRE)--Hutchison China MediTech Limited (“Chi-Med”) (AIM: HCM) announces that it intends to offer and sell, subject to market and other conditions, approximately $100 million of its ordinary shares in the form of American depositary shares (“ADSs”) in the United States (the “Offering”).
The final price per ADS placed in the potential Offering will be determined following the book-building process. Chi-Med intends to grant the underwriters a 30-day option to purchase additional ADSs in connection with the potential Offering at the final offering price.
The final price per ADS placed in the potential Offering will be determined following the book-building process. Chi-Med intends to grant the underwriters a 30-day option to purchase additional ADSs in connection with the potential Offering at the final offering price.
